Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB.

Dendritic cells (DCs) are important for presenting antigen to T cells, especially naïve T cells. It has recently been shown that blocking the transcription factor, nuclear factor kappa B (NF-kappaB) in human DCs inhibited the mixed leukocyte reaction. The aim of this study was to investigate the eff...

Full description

Bibliographic Details
Main Authors: Calder, V, Bondeson, J, Brennan, F, Foxwell, B, Feldmann, M
Format: Journal article
Language:English
Published: 2003
_version_ 1797053920294469632
author Calder, V
Bondeson, J
Brennan, F
Foxwell, B
Feldmann, M
author_facet Calder, V
Bondeson, J
Brennan, F
Foxwell, B
Feldmann, M
author_sort Calder, V
collection OXFORD
description Dendritic cells (DCs) are important for presenting antigen to T cells, especially naïve T cells. It has recently been shown that blocking the transcription factor, nuclear factor kappa B (NF-kappaB) in human DCs inhibited the mixed leukocyte reaction. The aim of this study was to investigate the effect of blocking NF-kappaB in DCs during presentation of antigen to memory T cells in vitro. Peripheral blood monocytes were differentiated into immature DCs with interleukin-4 (IL-4) and granulocyte-macrophage colony-stimulating factor, and pulsed with an immunogenic tetanus toxoid peptide. Upon maturation, the antigen-pulsed DCs were highly effective in presenting antigen to autologous T cells. However, stimulation with antigen-pulsed DCs overexpressing IotakappaBetaalpha, the endogenous inhibitor of NF-kappaB, led to a significant reduction in T-cell proliferation, and decreased production of interferon-gamma, IL-4 and IL-10, whereas transforming growth factor-beta production was low throughout. There was a significant increase in apoptosis of antigen-specific T cells, even in the presence of IL-2, which was not found in resting T cells. Similar findings were observed using a proteasome inhibitor to block NF-kappaB. The effective downregulation of antigen-specific T-cell responses following blockade of NF-kappaB in DCs could be a useful approach for immunomodulating inflammatory T-cell responses.
first_indexed 2024-03-06T18:50:19Z
format Journal article
id oxford-uuid:10018282-f7a1-4c69-ab00-85ddf49c278b
institution University of Oxford
language English
last_indexed 2024-03-06T18:50:19Z
publishDate 2003
record_format dspace
spelling oxford-uuid:10018282-f7a1-4c69-ab00-85ddf49c278b2022-03-26T09:54:07ZAntigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:10018282-f7a1-4c69-ab00-85ddf49c278bEnglishSymplectic Elements at Oxford2003Calder, VBondeson, JBrennan, FFoxwell, BFeldmann, MDendritic cells (DCs) are important for presenting antigen to T cells, especially naïve T cells. It has recently been shown that blocking the transcription factor, nuclear factor kappa B (NF-kappaB) in human DCs inhibited the mixed leukocyte reaction. The aim of this study was to investigate the effect of blocking NF-kappaB in DCs during presentation of antigen to memory T cells in vitro. Peripheral blood monocytes were differentiated into immature DCs with interleukin-4 (IL-4) and granulocyte-macrophage colony-stimulating factor, and pulsed with an immunogenic tetanus toxoid peptide. Upon maturation, the antigen-pulsed DCs were highly effective in presenting antigen to autologous T cells. However, stimulation with antigen-pulsed DCs overexpressing IotakappaBetaalpha, the endogenous inhibitor of NF-kappaB, led to a significant reduction in T-cell proliferation, and decreased production of interferon-gamma, IL-4 and IL-10, whereas transforming growth factor-beta production was low throughout. There was a significant increase in apoptosis of antigen-specific T cells, even in the presence of IL-2, which was not found in resting T cells. Similar findings were observed using a proteasome inhibitor to block NF-kappaB. The effective downregulation of antigen-specific T-cell responses following blockade of NF-kappaB in DCs could be a useful approach for immunomodulating inflammatory T-cell responses.
spellingShingle Calder, V
Bondeson, J
Brennan, F
Foxwell, B
Feldmann, M
Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB.
title Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB.
title_full Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB.
title_fullStr Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB.
title_full_unstemmed Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB.
title_short Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB.
title_sort antigen specific t cell downregulation by human dendritic cells following blockade of nf kappab
work_keys_str_mv AT calderv antigenspecifictcelldownregulationbyhumandendriticcellsfollowingblockadeofnfkappab
AT bondesonj antigenspecifictcelldownregulationbyhumandendriticcellsfollowingblockadeofnfkappab
AT brennanf antigenspecifictcelldownregulationbyhumandendriticcellsfollowingblockadeofnfkappab
AT foxwellb antigenspecifictcelldownregulationbyhumandendriticcellsfollowingblockadeofnfkappab
AT feldmannm antigenspecifictcelldownregulationbyhumandendriticcellsfollowingblockadeofnfkappab